Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;62(9):11382-11402.
doi: 10.1007/s12035-025-04950-1. Epub 2025 Apr 25.

TREK- 1 Ameliorates Secondary Brain Injury by Regulating Inflammatory Microenvironment via CX3 CL1-CX3 CR1 Pathway After Intracerebral Hemorrhage

Affiliations

TREK- 1 Ameliorates Secondary Brain Injury by Regulating Inflammatory Microenvironment via CX3 CL1-CX3 CR1 Pathway After Intracerebral Hemorrhage

Yongkang Fang et al. Mol Neurobiol. 2025 Sep.

Abstract

Neuroinflammation plays a pivotal role in the pathogenesis of secondary brain injury (SBI) after intracerebral hemorrhage (ICH). TREK-1 is a background potassium channel, and its role in regulating neuroinflammation after ICH remains unclear. In this study, ICH models were induced in wide-type (WT) and TREK knockout mice via intra-striatal administration of collagenase. Additionally, WT ICH mice were treated with the TREK-1 agonist ML67-33. Immunofluorescence, western blot, quantitative real-time PCR, enzyme-linked immunosorbent assay, and RNA-sequencing were performed to determine the role and the mechanism of TREK-1 in regulating neuroinflammation after ICH. The results indicate that TREK-1 deficiency exacerbated microglia/macrophages activation and pro-inflammatory polarization, as well as the influx of inflammatory cytokines and peripheral inflammatory cells compared to WT ICH mice. Conversely, activation of TREK-1 attenuated the inflammatory response and SBI post-ICH. These effects may be mediated through the CX3CL1-CX3CR1 pathway, as validated by specific inhibitors AZD8797. This study identified TREK-1 as a crucial modulator in alleviating SBI by regulating the inflammatory microenvironment via the CX3CL1-CX3CR1 pathway.

Keywords: CX3 CL1-CX3 CR1; Inflammatory microenvironment; Intracerebral hemorrhage; Secondary brain injury; TREK- 1.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval: All animal experimental protocols were authorized by the Institutional Animal Care and Use Committee of Tongji Medical College, Huazhong University of Science and Technology (Ethics approval number: TJH- 202001002). Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Ma Q, Li R, Wang L, Yin P, Wang Y, Yan C, Ren Y, Qian Z et al (2021) Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 6(12):e897–e906. https://doi.org/10.1016/s2468-2667(21)00228-0 - DOI - PubMed - PMC
    1. GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol 20(10):795–820. https://doi.org/10.1016/s1474-4422(21)00252-0 - DOI
    1. Liddle LJ, Ralhan S, Ward DL, Colbourne F (2020) Translational intracerebral hemorrhage research: has current neuroprotection research ARRIVEd at a standard for experimental design and reporting? Transl Stroke Res 11(6):1203–1213. https://doi.org/10.1007/s12975-020-00824-x - DOI - PubMed - PMC
    1. Rennert RC, Signorelli JW, Abraham P, Pannell JS, Khalessi AA (2015) Minimally invasive treatment of intracerebral hemorrhage. Expert Rev Neurother 15(8):919–933. https://doi.org/10.1586/14737175.2015.1059755 - DOI - PubMed
    1. Li Z, Khan S, Liu Y, Wei R, Yong VW, Xue M (2022) Therapeutic strategies for intracerebral hemorrhage. Front Neurol 13:1032343. https://doi.org/10.3389/fneur.2022.1032343 - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources